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a  b  s  t  r  a  c  t
We  developed  a system  for  tracing  DNA adducts  in  targeted  mutagenesis  (TATAM)  and  investigated
the  prevalence  and  types  of  consequent  mutations.  Targeted  mutagenesis  methods  site-speciﬁcally
replace  endogenous  DNA  bases  with  bases  carrying  synthetic  adducts  using  targeting  vectors.  The  TATAM
system  was enabled  by introduction  of  site-speciﬁc  DNA  double  strand  breaks  (DSB), which  strongly
enhanced  targeting  efﬁciency  through  homologous  recombination  (HR),  and  a  new  polymerase  chain
reaction-based  technique,  which  gives  high  yields  of the target  vectors  carrying  DNA  adducts.  Human
lymphoblastoid  TSCER122  cells are  compound  heterozygous  for  the  thymidine  kinase  gene  (TK−/−),  and
have  a homing  endonuclease  I-SceI  site  in intron  4 of  the  TK gene.  The  TATAM  system  enabled  targeting
of  the  TK− allele  with  the  I-SceI  site using  a  synthetic  TK+  allele  containing  an 8-oxo-7,8-dihydroguanine
(8-oxoG)  adduct,  a typical  product  of  oxidative  DNA  damage.  The  targeted  clones  (TK+/−)  were  then  iso-
lated  by drug  selection.  Site-speciﬁc  HR  for  DSB  induced  by  I-SceI  improved  targeted  integration  of  the
synthetic  allele  by ﬁve  orders  of magnitude  (from  10−7 to  10−2). Subsequent  analyses  of  approximately
800  target  clones  revealed  that  8-oxoG  was  restored  to  G  in 86%  clones,  probably  reﬂecting  base  excision
repair  or  translesion  synthesis  without  mutation.  Lesions  of the  remaining  clones  (14%) were  associ-
ated  with  mutations.  The  mutation  spectrum  corresponded  closely  with  that of  oxidative  DNA  damage
inducers  reported,  in  which  G:C  to  T:A  transversions  (5.9%)  were  predominant.  Over-expression  of  MutY
homologs  in cells,  which  prevents  G:C  to  T:A  transversions  by removing  8-oxoG:A  mispairing,  signiﬁ-
cantly  decreased  the  frequency  of  mutations  to 2.6%,  indicating  that the  8-oxoG  adducts  introduced  by
the  TATAM  system  are  processed  in the  same  manner  as  those  generated  by oxidative  DNA  damage.
© 2014  The  Authors.  Published  by Elsevier  B.V.  Open access under CC BY-NC-ND license.. Introduction
Humans are frequently exposed to thousands of potentially
armful dietary and environmental chemicals, many of which
ind DNA and produce DNA adducts [1,2]. Furthermore, numer-
us known and unknown DNA adducts are constitutively present
Abbreviations: TATAM, tracing DNA adducts in targeted mutagenesis; 8-oxoG,
-oxo-7,8-dihydroguanine; TK, thymidine kinase gene; HR, homologous recombi-
ation; DSB, double-strand break; MYH, human MutY homolog.
∗ Corresponding author. Tel.: +81 3 3700 1141x434; fax: +81 3 3700 2348.
∗∗ Corresponding author. Tel.: +81 3 3700 9872; fax: +81 3 3700 2348.
E-mail addresses: m-yasui@nihs.go.jp (M.  Yasui), honma@nihs.go.jp (M. Honma).
ttp://dx.doi.org/10.1016/j.dnarep.2014.01.003
568-7864 © 2014 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND liin human genomes, indicating exposure to DNA-reactive agents
[3,4]. Owing to apoptotic and DNA repair mechanisms that
eliminate premutagenic cells, not all DNA adducts lead to mutations
[5–8]. However, numerous known mutagenic DNA-reactive agents
produce speciﬁc gene mutations that are potentially carcinogenic.
Although  relationships between speciﬁc DNA  adducts and their
characteristic mutagenic properties have been established, that
between speciﬁc DNA adducts and mutations remain elusive.
Indeed, multiple DNA adducts are often produced by single muta-
gens such as aﬂatoxin B1 and it remains unknown which of
these are associated with major mutational events [9–11]. Studies
of site-speciﬁc mutagenesis, DNA repair, and bypass using site-
speciﬁcally modiﬁed oligonucleotides to monitor the fate of a DNA
adduct induced by chemicals and radiation have been reviewed [9].
Numerous studies have employed extra-chromosomal approaches
with episomal vectors, in which adduct-modiﬁed oligodeoxynu-
cleotides are ligated into single- or double-stranded vectors
cense.
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ontaining replication origins and are transfected into cells
9,12–17]. These episomal vectors independently replicate from the
ost genome. However, DNA adducts may  be processed via differ-
nt mechanisms to those occurring in the genome. To demonstrate
irect association between DNA adducts and genomic mutations,
NA adducts must be directly introduced into host genomes for
ubsequent investigations of their effects.
Site-speciﬁc intra-chromosomal mutagenesis was ﬁrst reported
y Essigmann and colleagues [18,19]. In these studies, SV40 vec-
ors containing single adducts were randomly integrated into the
enomes of Chinese hamster ovary cells. Subsequently, clones
ere isolated by drug selection, and the DNA at the adduct sites
as sequenced. In a more recent study, Izhar et al. developed
 unique system using phage integrase-mediated integration of
lasmid-borne synthetic DNA adducts with deﬁned site-speciﬁc
NA lesions into mammalian genomes [20]. This unique system
emonstrated the genetic consequences of the 6-4 photoproduct
nd benzo[a]pyrene-guanine adduct after processing of translesion
NA synthesis (TLS) and homology-dependent repair in the human
enome.
We previously developed a system for tracing the genetic
onsequences of DNA double strand breaks (DSBs) by intro-
ucing the homing endonuclease I-SceI site into intron 4 of
he thymidine kinase gene (TK) in human lymphoblastoid TK6
ells [21–23]. These experiments showed that the I-SceI-inducing
SB signiﬁcantly enhanced homologous recombination (HR). In
he present study, we developed a unique system for tracing
NA adducts in targeted mutagenesis (TATAM) that can site-
peciﬁcally replace endogenous DNA bases in intron 4 of TK
ene with bases containing a synthetic DNA adducts (Fig. 1).
ubsequently, we traced the genetic consequences of the inte-
rated DNA adduct. DSB enabled high gene targeting efﬁciency
or the TATAM system following enhanced site-speciﬁc HR for
SB repair [24,25]. Using the TATAM system, we also stably intro-
uced an 8-oxo-7,8-dihydroguanine (8-oxoG) adduct, which is
 typical product of oxygen radical-forming agents, into non-
ranscribed (NTS) and transcribed strands (TS) of TK gene at high
requency. This is the ﬁrst report to trace the fate of a DNA
dduct occurring in an endogenous single-copy gene in the human
enome.
. Materials and methods
.1.  Cell culture
Cells  were cultured in RPMI 1640 medium (Nacalai Tesque
orp., Kyoto, Japan) supplemented with 10% heat-inactivated horse
erum (JRH Biosciences, Lenexa, KS, USA), 200 g/ml sodium
yruvate, 100 U/ml penicillin, and 100 g/ml streptomycin, and
05–106 cells/ml were maintained at 37 ◦C in 5% CO2 and 100%
umidity.
.2. Construction of TSCER122 cells
TSCER122 human lymphoblastoid cells were isolated from
SCE105 cells [22], which were derived from TK6 cells [26].
SCE105 (TK+/−) cells are heterozygous for a point mutation in
xon 4 of the TK gene and have two I-SceI recognition sites
urrounding exon 5 of the TK allele. The I-SceI expression vec-
or pCBASce (50 g) was transfected into TSCE105 (5 × 106) cells
hat were suspended in 0.1 ml  of Nucleofector solution V (Amaxa
iosystem, Koeln, Germany) using Nucleofector I according to the
anufacturer’s recommendations [27]. Subsequently, cells were
eeded into 96-microwell plates at 1 cell/well. Two weeks later,
K-deﬁcient mutants (TK−/−) were isolated in the presence ofir 15 (2014) 11–20
2.0  g/ml triﬂuorothymidine (TFT). Mutants were independently
expended and DNAs were analyzed. DSBs occurring at the two
I-SceI sites in TSCE105 cells were correctly fused by error-free end-
joining, and produced a new I-SceI site with a 356-bp deletion
containing the entire exon 5. The resulting TK-deﬁcient mutant
TSCER122 (Fig. 3A) was conﬁrmed by drug resistance, I-SceI diges-
tion, and DNA sequencing experiments.
2.3. Construction of MYH-overexpressing TSCER122 cells
The  coding region of the human MutY homolog gene (MYH)
was ampliﬁed from cDNA of TK6 human lymphoblastoid cells
using polymerase chain reaction (PCR) with the primers 5′-TGG
GAA TTC GCC ACC ATG AGG AAG CCA CG-3′ and 5′-TTT CAG
TCG ACT CAC TGG GCT GCA CTG TT-3′. PCR products were
digested using EcoRI/SalI restriction enzymes and were cloned into
the EcoRI/SalI site of the pCI-neo Mammalian Expression Vector
(Promega Corp., Madison, WI). The resulting pCI-MYH3 con-
tained variant beta 3, which is known to localize in the nucleus
[28,29]. TSCER122 cells (5 × 106) were transfected with 10 g
XmnI-linearized pCI-MYH3 using Nucleofector I, were cultured for
48 h, and were then seeded into 96-microwell plates in the presence
of 0.6 mg/ml  G418 (Sigma-Aldrich, St. Louis, MO,  USA). G418-
resistant clones were then isolated and MYH  protein expression
was quantiﬁed using western blotting analyses and ImageGauge
software (Fujiﬁlm, Tokyo, Japan). MYH  protein expression was
normalized to -actin, and was  compared to that in wild type
cells.
2.4. PCR-based preparation of a site-speciﬁcally modiﬁed
targeting vector containing a single 8-oxoG adduct
The targeting vector pvINT8OxG, which contained a single 8-
oxoG adduct, and the control vector pvINTG were prepared as
described previously [30]. In brief, the method involved the fol-
lowing: (i) primer design, (ii) PCR ampliﬁcation, (iii) isolation and
self-annealing of four single-stranded (ss) DNA fragments originat-
ing from four individual PCR amplicons, and (iv) T4 DNA ligation
(Fig. 2A). The plasmid pTK15 (9-kb) was  derived from pTK10 [21,22]
and was  used as a PCR template. This plasmid vector comprises
6.1-kb of the original TK gene, encompassing exons 5–7, and the
part of I-SceI sequence in intron 4, which carries a loss of func-
tion TTAT deletion. We  inserted 8-oxoG into the pvINT8OxG vector
in place of the central guanine at the BssSI site in the NTS (5′-
CTCGTG in Primer 3F) of TK gene (Fig. 2B). Moreover, we  labeled
a 5′-TTCA-sequence (MseIR) near the 8-oxoG-modiﬁed BssSI site
that was resistant to MseI digestion, and thereby distinguished
between targeted and non-targeted revertants according inter-
allelic recombination (Fig. 3B). Twenty primers were designed to
amplify sequential 300-bp fragments from the end of the 6.1-kbp
targeting vector, and the whole sequence was analyzed using an
ABI 3730xl 96-capillary DNA analyzer (Applied Biosystems, Foster
City, CA, USA).
2.5. Transfection and cloning of TK revertant cells using the
TATAM  system
TSCER122 (5 × 106) cells were suspended in 0.1 ml  Nucleofec-
tor Solution V and were co-transfected with 50 g of pCBASce
vector and 2 g of targeting vector (pvINT8OxG or pvINTG)
using Nucleofector I according to the manufacturer’s recom-
mendations [27]. Subsequently, cells were cultured for 72 h and
were then seeded into 96-microwell plates in the presence of
HAT (200 M hypoxanthine, 0.1 M aminopterin, and 17.5 M
thymidine) to isolate 8-oxoG-integrated revertant clones. Drug-
resistant colonies were counted 2 weeks later, frequencies of TK
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Fig. 1. Outline of the tracing DNA adducts in targeted mutagenesis (TATAM) system. The human lymphoblastoid cell line TSCER122 is compound heterozygous for thymidine
kinase gene (TK−/−) and has a single I-SceI endonuclease site. TSECR122 cells were co-transfected with the 8-oxoG-modiﬁed targeting vector pvINT8OxG and the I-SceI
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cxpression plasmid pCBASce. Three days after transfection, cells were seeded into 96
ubsequently, the TK gene containing 8-oxoG was sequenced. I-SceI-induced doub
ecombination (HR) and resulted in insertion of 8-oxoG into the genome.
evertants were calculated according to the Poisson distribution
31], and TK revertants were independently cultured for DNA
nalysis.
.6. Mutation analysis at 8-oxoG adduct lesions
High-purity TSCER122 genomic DNAs were isolated from the
K revertant clones on 96-microwell plates using DNeasy 96 Blood
 Tissue Kits (QIAGEN), and the mutation spectrum of 8-oxoG
ntroduced by pvINT8OxG integration was analyzed (Fig. 3). Subse-
uently, the TK gene fragments containing the 8-oxoG-integration
ite were ampliﬁed by PCR using KOD FX polymerase with the for-
ard and reverse primers: (Pri#291, intron 4), 5′-GCT CTT ACG
AA AAG GAA ACA GG-3′; (Pri#292, intron 5), 5′-CTG ATT CAC AAG
AC TGA AG-3′, respectively. PCR ampliﬁcation was  performed with
enaturation at 96 ◦C for 5 min  followed by 25 cycles of 96 ◦C for
0s, 57 ◦C for 30s, and 68 ◦C for 1 min. Regions around the BssSI and
seIR sites were sequenced using an ABI 3730xl DNA analyzer and
lones harboring the MseIR sequence were counted to determine
he frequency of 8-oxoG integration and numbers of mutations at
he BssSI site. Subsequently, the integration frequency of 8-oxoG
dducts in the pvINT8OxG targeting vector was calculated by divid-
ng the number of MseIR clones by the total number of revertant
lones analyzed. Point mutation frequencies opposite the 8-oxoG
ite were also calculated by dividing the number of single-base
ubstitutions, deletions, and insertions by the number of MseIR-
earing clones (Table 1).
.7. Non-targeting vectors for competitive assays of 8-oxoG repair
Double-stranded (ds) 100-bp DNAs [5′-GGT ACC GGG CCC CCC
TC GAG GTC GAC GGT ATC GAT AAG CTT AGC CTC XTGGGA CTG
AG CCC GGG GGA TCC ACT AGT TCT AGA GCG GCC GCC ACC
CG G (X = G or 8-oxoG)] with nonspeciﬁc sequences contain-
ng unmodiﬁed G or 8-oxoG in BssSI recognition sequences, from
apan Bioservice Corp. (Saitama, Japan). Subsequently, noncom-
etitive (pvINT8OxG vector and the unmodiﬁed 100-bpsG dsDNA)
nd competitive (pvINT8OxG vector and the 8-oxoG-modiﬁed
00-bps8OxG dsDNA) combinations of vectors and dsDNAs were
o-transfected in the presence of the I-SceI expression vectorwell plates in the presence of HAT to isolate 8-oxoG-integrated TK-revertant clones.
nd breaks (DSB) enhanced the gene targeting efﬁciency by inducing homologous
(50 g) into 5 × 106 TSCER122 cells using Nucleofector I according
to the manufacturer’s instructions[27]. The molar ratio between
targeting vector and non-targeting vector in both noncompeti-
tive (pvINT8OxG:dsDNA 100-bpsG) and competitive experiments
(pvINT8OxG:dsDNA 100-bps8OxG) was  approximately 1:60. After
transfection, cells were cultured for 3 days and were then seeded
into 96-microwell plates in the presence of HAT to isolate 8-
oxoG-integrated revertant clones. Drug-resistant colonies were
then counted 2 weeks later and were independently cultured for
sequencing analysis.
2.8.  The TATAM system for 8-oxoG adducts in TS of the TK gene
Initially,  8-oxoG was introduced into NTS of the TK gene accord-
ing to the TATAM system. To compare the mutation properties
of 8-oxoG between NTS and TS of the TK gene, we also pre-
pared a pvIT8OxG targeting vector for the TS of the TK gene. An
oligonucleotide primer (R2) containing 8-oxoG was then synthe-
sized (Supplementary Fig. S1) and the pvIT8OxG-targeting vector
for TS was prepared as described above.
3. Results
3.1. Preparation of the 8-oxoG-modiﬁed targeting vector
We  prepared pvINT8OxG and pvINTG targeting vectors using syn-
thetic 8-oxoG-modiﬁed and unmodiﬁed primers, respectively, as
starting materials (Fig. 2). DNA sequencing conﬁrmed the absence
of errors in the entire 6.1-kbp targeting vectors sequence. A stalled
peak was also detected at the 8-oxoG-neighboring base site of the
pvINT8OxG vector, but not at the same site in the pvINTG vector (Sup-
plementary Fig. S2), indicating that 8-oxoG adduct was  present at
the expected site in pvINT8OxG vector, and pvINTG vector can be
used as control.
3.2.  Frequency of TK revertant TSCER122 cells in the TATAM
system
TSCER122 cells (TK−/−) are compound heterozygous for TK
because of a 356-bp deletion of exon 5 on one TK allele, and a point
14 M. Yasui et al. / DNA Repair 15 (2014) 11–20
Fig. 2. PCR-based construction of a targeting vector containing a single 8-oxoG. (A) Diagram of pvINT8OxG vector preparation; The P and B at the 5′-terminus of the
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utation in exon 4 on the other TK allele. An I-SceI site exists on the
riginal exon 5 region (Fig. 3A), which allows generation of wild-
ype TK by correct targeting using pvINT8OxG or pvINTG vectors.
ubsequently, TK revertant clones (TK+/−) can be selected using
AT (Fig. 3B). Gene targeting only with pvINTG vector yielded a very
ow frequency of TK revertants (10−7). In contrast, co-transfection
ith pvINT8OxG or pvINTG vectors and the I-SceI expression vector
CBASce increased the frequency of TK revertants to approximately
0−2 (Fig. 4A), indicating that HR-mediated repair of DSB at the I-
ceI site enhances targeting efﬁciency. Interestingly, TK revertant
requencies did not differ between cells transfected with pvINT8OxG
nd pvINTG vectors, indicating that the 8-oxoG adduct in the tar-
eting vector was efﬁciently delivered to the genome (Fig. 4A).
oreover, in cells transfected with only pCBASce, revertant fre-
uencies were signiﬁcantly increased from 10−4 to 10−3 [18–20]
Fig. 4A), indicating that approximately 10% of TK revertants in theails of the site of 8-oxoG modiﬁcation; the adduct is indicated by “8” in Primer
GTG in Primer 3F) to generate the pvINT8OxG vector. The MseIR site was also placed
TATAM system are generated by inter-allelic HR, but not by gene
targeting. These revertants were distinguished using the molecular
analyses reported below.
TK revertant frequencies were constant until 72 h (Fig. 4B), sug-
gesting that the targeting vector is integrated immediately into
the TSCER122 genome. Moreover, TK revertant clones increased
linearly with quantities of pvINTG targeting vector in the TATAM
system (Fig. 4C), indicating that under the present conditions the
TATAM system is quantitative and reproducible.
3.3. Determination of mutation frequencies and spectra at
integrated  8-oxoG lesionsTable  1 shows mutation frequencies and spectra associated with
integration of single 8-oxoG adducts by each targeting vector. The
frequencies of pvINTG- (770/888 or 88%) and pvINT8OxG-targeted
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Fig. 3. (A) Development of TSCER122 cells used in the TATAM system. TSCE105 (TK+/−) is heterozygous for a point mutation in exon 4 of the TK gene and has two I-SceI
recognition sites surrounding exon 5 of the TK+ allele. Following transfection of the I-SceI expressing vector, DSB occurring at the two I-SceI sites were correctly fused by
error-free end-joining and produced a new I-SceI site with a 356-bp deletion containing the entire exon 5, resulting in the TK-deﬁcient mutant TSCER122. (B) Principle of the
use  of HR in the TATAM system. The 8-oxoG-modiﬁed targeting vector pvINT8OxG (or pvINTG as a control) and the I-SceI expression plasmid pCBASce were co-transfected
into TSCER122 cells. The DSB occurring at the I-SceI site enabled high gene targeting efﬁciency for the TATAM system by inducing DSB-repair enhanced site-speciﬁc HR. The
targeting  vectors contained MseIR sites, which do not exist in the native TK gene and thereby distinguish between targeted and nontargeted revertants. Genomic DNAs were
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uished using MseI  enzyme cleavage analyses (Fig. 2B).d site was  ampliﬁed by PCR using the primers Pri#291 and #292, as described inAmong the sequenced sites generated by integration of 8-
oxoG, 86% were repaired or bypassed without causing mutations.
Among the remaining 14% of mutations, G:C to T:A transver-
sions were predominant (5.9%), followed by single-base deletions
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Fig. 4. TK revertant frequencies induced by pCBASce and targeting vectors. (A) I-
SceI expression vector (pCBASce) and/or pvINT8OxG vector (or pvINTG as a control)
were  transfected into TSCER122 cells. Three days later, cells were seeded into 96-
microwell plates in the presence of HAT to select for TK-revertant clones. Two weeks
later, microwells containing drug-resistant colonies were counted, and TK-revertant
frequencies  were calculated. (B) No effect of expression period on the frequency of
TK-revertants; after transfection, cells were cultured for 12, 24, 48, or 72 h, and were
then seeded into 96-microwell plates. (C) Dose-dependent relationship between TK-
revertant frequency and the amount of pvINTG targeting vector; pCBASce (50 g)
and pvINTG (0.4, 1, or 2 g) vectors were co-transfected into TSCER122 cells and
TK-revertant  frequency increased linearly with increasing quantities of pvINTG tar-
geting vector.
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Table  2
Properties of miscellaneous base changes and large deletions at BssSI site.
Other base-changesa pvINTG pvINT8OxG
TSCER122 TSCER122 TSCER122MYH
5′-ctc8tg (original)
5′-cttgtg 6 1 2
5′-ctcgag 1 1 1
5′-cccgtg 2  2
5′-ctcgta 1 1
5′-cttcgtg 2 1
5′-ctctttg 1  2
5′-cccttg 1
5′-ctattg 1
5′-ctcgg 1
5′-ctggtg 2
5′-ctcgttg 2
5′-ctcgtcg 1
5′-ctctgg 1
5′-ctcttgg 1
5′-cttctg 2
5′-ctcattg 1
5′-ttcttg 1
5′-ctctatg 1
135-bp deletion 1b
6-bp deletion 1c
33-bp deletion 1d
Total 12 18 12
a “8” and “” indicate 8-oxoG and single-base deletion, respec-
tively.
b 5′-gctgcgcagttgtggatgtacctgtcgtctgctggggggcgtgcgggtggacacagtcc-
cccggcctggggagcctcgtgggagaattaagagttactccgggccaaatggccggagttgtca-
g
(
v
T
f
w
w
t
s
3
m
t
w
t
e
v
b
q
p
n
v
8
t
3
c
5
Matccattacc.
c 5′-cctcgt.
d 5′-gagcctcgtgggagaattaagagttactccggg.
2.1%) and G:C to C:G transversions (1.2%). In contrast, control
ector integrated lesions did not produce any point mutations.
able 2 shows the miscellaneous base changes observed at low
requency. Base substitutions, single-base deletions and insertions
ere observed around the 8-oxoG sites. Some of these mutations
ere also observed in the control experiment (pvINTG). However,
hree deletional mutations (6, 33, and 135-bp) containing 8-oxoG
ite observed in cells transfected only with pvINT8OxG.
.4. Stability of 8-oxoG in pvINT8OxG before targeting integration
DNA  repair enzymes such as 8-oxoguanine glycosylase (OGG1)
ay remove 8-oxoG adducts after transfection of plasmid vec-
ors before integration into the genome [28,32,33]. Thus, assays
ere performed with competitive 100-bps8OxG and noncompeti-
ive 100-bpsG vectors that cannot act as targeting vectors. In these
xperiments, if the 8-oxoG adduct is efﬁciently excised from the
ectors, the revertant frequency with the competitive vector should
e higher than with the non-competitive vector. However, the fre-
uencies of base changes in the BssSI cleavage site, which was  not
resent in the revertants (Fig. 3B), were 18.7 ± 2.0% (26/139) for the
oncompetitive vector and 14.3 ± 2.3% (19/132) for the competitive
ector. These frequencies did not differ signiﬁcantly, indicating that
-oxoG was not efﬁciently excised from the targeting vector prior
o integration into the genome.
.5. Decreased mutation frequencies of 8-oxoG in TSCER122MYH
ellsMYH-overexpressing TSCER122MYH cells were isolated from
 × 106 TSCER122 cells transfected with XmnI-linearized pCI-
YH3 and cultured in 96-microwell plates in the presence ofir 15 (2014) 11–20 17
G418,  as described in Section 2. MYH  expression was  2.1-times
higher in TSCER122MYH cells than in wild-type TSCER122 cells
(Supplementary Fig. S3). Among the 619 genomic DNAs extracted
from TSCER122MYH clones, 507 (82%) were MseIR-bearing clones,
indicating that the integration frequency was similar to that of
the control (Table 1). The total point mutation frequency (8.7%)
decreased a little, but did not differ signiﬁcantly from that in wild-
type TSCER122 cells (10.7%). However, the fraction of G:C to T:A
transversions in TSCER122MYH cells (2.6%) was  2.3 times lower
than in wild-type cells (5.9%; Table 1).
3.6. 8-oxoG mutations did not differ between NTS and TS of the
TK  gene
Initially, the TATAM system was  devised for NTS of the TK gene.
Subsequently, we  analyzed consequences of 8-oxoG adducts in
both NTS and TS of the TK gene (Table 3). Introduction of 8-oxoG
into the TK-TS side of the BssSI site (Supplementary Fig. S1) caused
a total point mutation frequency of 10.6%, which was similar to that
in the NTS side (10.7%). Mutation spectra were also similar between
NTS and TS of the TK gene. Interestingly, no single-base deletions
were detected in the TS side, whereas the frequency of single-base
deletions at the NTS side was  2.1% (Table 3).
4. Discussion
Because the frequency of HR in mammalian cells is generally
low, the gene targeting efﬁciency through HR is <10−6 [34,35].
In contrast, gene targeting integration using the present TATAM
system (Figs. 1 and 3) was  10−3 to 10−2 (Fig. 4). This dramatic
enhancement of gene targeting efﬁciency was  achieved by site-
speciﬁc I-SceI, which produces DSB that strongly initiates HR
[24,25]. In addition, TK revertant frequencies increased linearly
with the quantity of targeting vector (Fig. 4C), indicating that gene
targeting in the TATAM system is not saturated by the targeting
vector under the present conditions, enabling quantitative com-
parison of the gene targeting efﬁciencies. Using a new PCR-based
method, we prepared high yields (micrograms) of target vectors
containing DNA adducts within 5 days. Thus, the TATAM system
allows efﬁcient recovery of adduct-integrated clones, and can be
used to investigate the genetic consequences of individual adducts
at speciﬁc sites in the human genome.
Oxidative damage by reactive oxygen species (ROS) occurs fre-
quently in all organisms. Reactions of ROS with DNA produce a
large variety of lesions on bases and sugars. Among these, the
biological importance of 8-oxoG is widely accepted because of its
abundance and mutagenicity [36]. The mutagenicity of 8-oxoG has
been well characterized in bacterial and mammalian cells. Speciﬁ-
cally, shuttle vectors carrying speciﬁc 8-oxoG sites predominantly
produce G:C to T:A transversions in E. coli and simian kidney cells
(COS-7) [15,37]. Kamiya et al. integrated a synthetic c-Ha-ras pro-
tooncogene containing 8-hydroxyguanine (8-ohG; hydroxyl form
of 8-oxoG) in the second position of codon 12 (GGC) into the
murine genome of NIH3T3 cells and demonstrated a preponder-
ance of G:C to T:A transversions among the resulting transformants
[38]. In another study, treatments of Ogg1 deﬁcient gpt trans-
genic mice with the oxidative agent potassium bromate (KBrO3)
caused tremendous accumulation of 8-ohG lesions in kidney DNA,
which produced a high frequency of mutations in the gpt gene [39].
Subsequent mutational spectra analyses revealed that G:C to T:A
transversions were the most prevalent, followed by G:C to A:T tran-
sitions and small deletions in both wild-type and Ogg1 deﬁcient gpt
transgenic mice.
The  TATAM system showed that 8-oxoG predominantly caused
G:C to T:A transversions followed by single base deletions. These
18 M. Yasui et al. / DNA Repa
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data are consistent with the above reports. However, only 14% of
8-oxoG lesions led to mutations in the system and the remaining
86% of 8-oxoG lesions were restored to G, probably through base
excision repair (BER) or TLS (Table 1). Because we did not use
drug selection to isolate mutants, the TATAM system enabled both
characterization of mutations and evaluation of the efﬁciency
of DNA repair and TLS. To investigate the effects of BER, we
constructed TSCER122MYH cells overexpressing the MYH  protein,
which removes adenine from 8-oxoG:A but not cytosine from
8-oxoG:C [29,40]. Overexpressed MYH  only works for 8-oxoG:A
that is generated by error-prone TLS. Accordingly, mutation fre-
quencies of G:C to T:A transversions were signiﬁcantly suppressed
in TSCER122MYH cells (2.6%), whereas other mutations occurred
with similar frequency, suggesting that MYH  in the TATAM system
speciﬁcally removes adenine from 8-oxoG:A mismatched pairs.
These results indicate that the 8-oxoG sites introduced by the
TATAM system are processed as those generated by oxidative
DNA damage. Use of additional cell types with overexpressed
or deﬁcient repair enzymes in the TATAM system will further
elucidate DNA repair and TLS mechanisms.
In the present study, the TATAM system characterized muta-
tions induced by xanthine and 8-bromoguanine adducts, which are
formed by reactions of ROS and reactive nitrogen species with gua-
nine bases in inﬂamed tissues [41–43]. As shown in Supplementary
Table S1, the predominant mutations (G:C to A:T transitions for
xanthine and single-base deletions for 8-bromoguanine) observed
in the TATAM system were consistent with previous in vitro stud-
ies [5,44–46]. Thus, the TATAM system accurately characterizes
mutation spectra of various endogenous DNA adducts in the human
genome.
In this study, we  investigated mutational properties of 8-oxoG
on TS and NTS of the TK gene using the TATAM system. It is
widely accepted that transcription-coupled repair (TCR) is initi-
ated upon irreversible stalling of RNA polymerase II on TS of bulky
pyrimidine dimers [47–49]. However, the mechanisms of trans-
criptional arrest at site-speciﬁc 8-oxoG adducts remain unknown.
Although pauses and partial blockage by the lesions has been
demonstrated using puriﬁed RNA polymerase II in vitro [50,51],
other studies show efﬁcient bypass of 8-oxoG lesions using cell
extracts and luciferase reporter assays [52–54]. Pastoriza-Gallego
et al. showed that transcriptional arrest by 8-oxoG can vary with
proximal promoter strengths and nucleotide sequences [54]. As
shown in Table 3, the mutational properties of 8-oxoG on NTS and
TS were almost the same, indicating that no preferential strand
repair of 8-oxoG adducts in the TK gene, and implying that the TCR
pathway is not initiated by such lesions.
Interestingly, single-base deletions were detected on NTS, but
not on TS in the TK gene, potentially reﬂecting the sequence con-
text of neighboring 8-oxoG rather than the TCR pathway. In a
previous study of mammalian cells, oligonucleotides containing
8-oxoG in shuttle vector systems predominantly produced G:C
to T:A transversions, whereas other frequently detected muta-
tions were inﬂuenced by neighboring sequences and no single
base deletions were observed [55]. Thus, the mechanisms behind
8-oxoG-associated single-base deletions in the present TATAM
experiments remain unclear. In in vitro DNA synthesis experiments
using synthetic templates, single-base deletions were generated
depending on the neighboring sequences and the polymerase used
(mammalian DNA polymerase , , and , and E. coli Klenow frag-
ment pol I or pol III) [56–58]. In contrast, single-base deletions,
particularly of guanine, were infrequently observed in transgenic
gene mutation assays after treatment of animals with KBrO3 [59].
The TATAM system detects unique mutations caused by 8-oxoG
(Table 2, 3). Because some mutations were also produced by the
control targeting vector pvINTG, artifactual effects of gene targeting
may cause occasional gene mutations. However, some mutations,
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articularly large deletions (6–135 bp), were only speciﬁcally gen-
rated by the pvINT8OxG vector (Table 3), implying an association
ith DSB. In the BER pathway, 8-oxoG is excised by DNA glycosylase
nd creates an abasic site, which is incised by AP endonucleases and
enerates single strand breaks. Repair of these lesions can lead to
SB through collapsed replication forks during cell cycle progres-
ion [60]. Hence introduction of DNA adducts into introns of the TK
ene using the TATAM system enables rescue from various genetic
onsequences of DNA adducts, such as large deletions, offering a
igniﬁcant advantage for investigations of mutation spectra, and
vading selection biases.
In conclusion, the TATAM system we developed here can be used
o introduce any synthetic DNA adduct into speciﬁc regions of the
uman genome, providing a valuable tool for quantitative inves-
igations of the fate of individual adducts in the human genome.
oreover, this method can be used to determine the biological
haracteristics and phenomena of DNA adducts in human cells
verexpressing or deﬁcient in speciﬁc enzymes, such as DNA poly-
erases and DNA repair proteins.
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